-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
High -X- _ O
rates -X- _ O
of -X- _ O
potentially -X- _ O
pathogenic -X- _ B-Intervention
bacteria -X- _ I-Intervention
and -X- _ I-Intervention
respiratory -X- _ I-Intervention
viruses -X- _ I-Intervention
can -X- _ O
be -X- _ O
detected -X- _ O
in -X- _ O
the -X- _ O
upper -X- _ B-Patient
respiratory -X- _ I-Patient
tract -X- _ I-Patient
of -X- _ I-Patient
healthy -X- _ I-Patient
children. -X- _ I-Patient
Investigating -X- _ O
presence -X- _ B-Outcome
of -X- _ O
and -X- _ O
associations -X- _ B-Outcome
between -X- _ O
these -X- _ O
pathogens -X- _ O
in -X- _ O
healthy -X- _ O
individuals -X- _ O
is -X- _ O
still -X- _ O
a -X- _ O
rather -X- _ O
unexplored -X- _ O
field -X- _ O
of -X- _ O
research -X- _ O
, -X- _ O
but -X- _ O
may -X- _ O
have -X- _ O
implications -X- _ O
for -X- _ O
interpreting -X- _ O
findings -X- _ O
during -X- _ O
disease. -X- _ O
METHODOLOGY -X- _ O
/ -X- _ O
PRINCIPAL -X- _ O
FINDINGS -X- _ O
: -X- _ O
We -X- _ O
selected -X- _ O
986 -X- _ B-Patient
nasopharyngeal -X- _ I-Patient
samples -X- _ I-Patient
from -X- _ I-Patient
433 -X- _ I-Patient
6- -X- _ I-Patient
to -X- _ I-Patient
24-month-old -X- _ I-Patient
healthy -X- _ I-Patient
children -X- _ I-Patient
that -X- _ O
had -X- _ O
participated -X- _ O
in -X- _ O
a -X- _ O
randomized -X- _ O
controlled -X- _ O
trial. -X- _ O
We -X- _ O
determined -X- _ O
the -X- _ O
presence -X- _ B-Outcome
of -X- _ I-Outcome
20 -X- _ I-Outcome
common -X- _ I-Outcome
respiratory -X- _ I-Outcome
viruses -X- _ I-Outcome
using -X- _ I-Outcome
real-time -X- _ I-Outcome
PCR. -X- _ I-Outcome
Streptococcus -X- _ I-Outcome
pneumoniae -X- _ I-Outcome
, -X- _ I-Outcome
Haemophilus -X- _ I-Outcome
influenzae -X- _ I-Outcome
, -X- _ I-Outcome
Moraxella -X- _ I-Outcome
catarrhalis -X- _ I-Outcome
and -X- _ I-Outcome
Staphylococcus -X- _ I-Outcome
aureus -X- _ I-Outcome
were -X- _ I-Outcome
identified -X- _ I-Outcome
by -X- _ I-Outcome
conventional -X- _ I-Outcome
culture -X- _ I-Outcome
methods. -X- _ I-Outcome
Information -X- _ O
on -X- _ O
risk -X- _ O
factors -X- _ O
was -X- _ O
obtained -X- _ O
by -X- _ O
questionnaires. -X- _ O
We -X- _ O
performed -X- _ O
multivariate -X- _ O
logistic -X- _ O
regression -X- _ O
analyses -X- _ O
followed -X- _ O
by -X- _ O
partial -X- _ O
correlation -X- _ O
analysis -X- _ O
to -X- _ O
identify -X- _ O
the -X- _ O
overall -X- _ O
pattern -X- _ O
of -X- _ O
associations. -X- _ O
S. -X- _ B-Outcome
pneumoniae -X- _ I-Outcome
colonization -X- _ I-Outcome
was -X- _ I-Outcome
positively -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
the -X- _ I-Outcome
presence -X- _ I-Outcome
of -X- _ I-Outcome
H. -X- _ I-Outcome
influenzae -X- _ I-Outcome
( -X- _ I-Outcome
adjusted -X- _ I-Outcome
odds -X- _ I-Outcome
ratio -X- _ I-Outcome
1.60 -X- _ I-Outcome
, -X- _ I-Outcome
95 -X- _ I-Outcome
% -X- _ I-Outcome
confidence -X- _ I-Outcome
interval -X- _ I-Outcome
1.18–2.16 -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
M. -X- _ I-Outcome
catarrhalis -X- _ I-Outcome
( -X- _ I-Outcome
1.78 -X- _ I-Outcome
, -X- _ I-Outcome
1.29–2.47 -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
human -X- _ I-Outcome
rhinoviruses -X- _ I-Outcome
( -X- _ I-Outcome
1.63 -X- _ I-Outcome
, -X- _ I-Outcome
1.19–2.22 -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
enteroviruses -X- _ I-Outcome
( -X- _ I-Outcome
1.97 -X- _ I-Outcome
, -X- _ I-Outcome
1.26–3.10 -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
negatively -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
S. -X- _ I-Outcome
aureus -X- _ I-Outcome
presence -X- _ I-Outcome
( -X- _ I-Outcome
0.59 -X- _ I-Outcome
, -X- _ I-Outcome
0.35–0.98 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
H. -X- _ I-Outcome
influenzae -X- _ I-Outcome
was -X- _ I-Outcome
positively -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
human -X- _ I-Outcome
rhinoviruses -X- _ I-Outcome
( -X- _ I-Outcome
1.63 -X- _ I-Outcome
, -X- _ I-Outcome
1.22–2.18 -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
respiratory -X- _ I-Outcome
syncytial -X- _ I-Outcome
viruses -X- _ I-Outcome
( -X- _ I-Outcome
2.78 -X- _ I-Outcome
, -X- _ I-Outcome
1.06–7.28 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
M. -X- _ I-Outcome
catarrhalis -X- _ I-Outcome
colonization -X- _ I-Outcome
was -X- _ I-Outcome
positively -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
coronaviruses -X- _ I-Outcome
( -X- _ I-Outcome
1.99 -X- _ I-Outcome
, -X- _ I-Outcome
1.01–3.93 -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
adenoviruses -X- _ I-Outcome
( -X- _ I-Outcome
3.69 -X- _ I-Outcome
, -X- _ I-Outcome
1.29–10.56 -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
negatively -X- _ I-Outcome
with -X- _ I-Outcome
S. -X- _ I-Outcome
aureus -X- _ I-Outcome
carriage -X- _ I-Outcome
( -X- _ I-Outcome
0.42 -X- _ I-Outcome
, -X- _ I-Outcome
0.25–0.69 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
We -X- _ I-Outcome
observed -X- _ I-Outcome
a -X- _ I-Outcome
strong -X- _ I-Outcome
positive -X- _ I-Outcome
association -X- _ I-Outcome
between -X- _ I-Outcome
S. -X- _ I-Outcome
aureus -X- _ I-Outcome
and -X- _ I-Outcome
influenza -X- _ I-Outcome
viruses -X- _ I-Outcome
( -X- _ I-Outcome
4.87 -X- _ I-Outcome
, -X- _ I-Outcome
1.59–14.89 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
In -X- _ I-Outcome
addition -X- _ I-Outcome
, -X- _ I-Outcome
human -X- _ I-Outcome
rhinoviruses -X- _ I-Outcome
and -X- _ I-Outcome
enteroviruses -X- _ I-Outcome
were -X- _ I-Outcome
positively -X- _ I-Outcome
correlated -X- _ I-Outcome
( -X- _ I-Outcome
2.40 -X- _ I-Outcome
, -X- _ I-Outcome
1.66–3.47 -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
as -X- _ I-Outcome
were -X- _ I-Outcome
enteroviruses -X- _ I-Outcome
and -X- _ I-Outcome
human -X- _ I-Outcome
bocavirus -X- _ I-Outcome
, -X- _ I-Outcome
WU -X- _ I-Outcome
polyomavirus -X- _ I-Outcome
, -X- _ I-Outcome
parainfluenza -X- _ I-Outcome
viruses -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
human -X- _ I-Outcome
parechovirus. -X- _ I-Outcome
A -X- _ I-Outcome
negative -X- _ I-Outcome
association -X- _ I-Outcome
was -X- _ I-Outcome
observed -X- _ I-Outcome
between -X- _ I-Outcome
human -X- _ I-Outcome
rhinoviruses -X- _ I-Outcome
and -X- _ I-Outcome
coronaviruses. -X- _ I-Outcome
CONCLUSIONS -X- _ O
/ -X- _ O
SIGNIFICANCE -X- _ O
: -X- _ O
Our -X- _ O
data -X- _ O
revealed -X- _ O
high -X- _ B-Outcome
viral -X- _ I-Outcome
and -X- _ I-Outcome
bacterial -X- _ I-Outcome
prevalence -X- _ I-Outcome
rates -X- _ I-Outcome
and -X- _ I-Outcome
distinct -X- _ I-Outcome
bacterial-bacterial -X- _ I-Outcome
, -X- _ I-Outcome
viral-bacterial -X- _ I-Outcome
and -X- _ I-Outcome
viral-viral -X- _ I-Outcome
associations -X- _ I-Outcome
in -X- _ I-Outcome
healthy -X- _ I-Outcome
children -X- _ I-Outcome
, -X- _ O
hinting -X- _ O
towards -X- _ O
the -X- _ O
complexity -X- _ O
and -X- _ O
potential -X- _ O
dynamics -X- _ O
of -X- _ O
microbial -X- _ O
communities -X- _ O
in -X- _ O
the -X- _ O
upper -X- _ O
respiratory -X- _ O
tract. -X- _ O
This -X- _ O
warrants -X- _ O
careful -X- _ O
consideration -X- _ O
when -X- _ O
associating -X- _ O
microbial -X- _ O
presence -X- _ O
with -X- _ O
specific -X- _ O
respiratory -X- _ O
diseases -X- _ O
. -X- _ O

